Form 4 for ALAB Astera Labs, Inc.
Accepted 2025-07-29 00:00:00 ET · period of report 2025-07-24 · accession 0001736297-25-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-29 | 2025-07-24 | ALAB | Tate Michael Truett | CFO | A - Grant | $0.00 | +43.2K | 278.4K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-24 | A | A | 43,238 | $0.00 | 278,373 | D | — | — | (F1) These shares represent an award of restricted stock units ("RSUs") granted on July 24, 2025 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on August 15, 2026 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |